---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-033097"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2023-09-27T23:59:59+00:00"
generated_at: "2026-06-10T08:09:37.137981+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Better Choice receives NYSE American non-compliance notice for low stock price; cure period to March 21, 2024

## Summary
- NYSE American notified Better Choice on Sept 21, 2023 that common stock traded at low price per share for substantial period, violating Section 1003(f)(v).
- Cure period ends March 21, 2024; compliance may require reverse stock split or sustained price improvement; stock will trade with 'BC' designation.
- Company intends to regain compliance and is in discussions with NYSE American; no immediate delisting or impact on business/SEC reporting.
- Company supplemented risk factors in Form 10-K regarding potential delisting consequences such as reduced liquidity and penny stock designation.

## SEC filing metadata
- accession: 0001628280-23-033097
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2023-09-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000162828023033097/0001628280-23-033097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000162828023033097/bttr-20230921.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-033097
- JSON: https://secwatch.observer/filing/0001628280-23-033097.json
- Plain text: https://secwatch.observer/filing/0001628280-23-033097.txt

## Key facts
- Listing & Compliance Notices
  SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 1003(f)(v)
  source text: September 21, 2023, Better Choice Company, Inc. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Section 1003(f)(v)”) because shares of the Company's common stock have been selling for a substantial period of time at a low price per share. The Notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000162828023033097/0001628280-23-033097-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.